Arvind Announces Launch Of Revolutionary Anti-Viral Fabrics Under Its “Intellifabrix” Brand — Partners With Swiss Textile Innovator HeiQ

MUMBAI — June 10, 2020 — While fabrics have been usually associated with fashion, as the world faces the COVID-19 crisis, there is an urgent need for antiviral fabrics in our daily lives. Arvind Ltd. today announced launch of anti-viral textile technology for the first time in India under its brand “Intellifabrix.” Arvind has partnered with Switzerland-based HeiQ Materials AG in association with Taiwanese Specialty chemical major M/S Jintex Corp. to introduce this revolutionary anti-virus technology in India.

Research shows that viruses and bacteria, can remain active on textile surfaces for up to two days. Garments treated with HeiQ Viroblock actively inhibit viruses and kill them upon contact, helping to minimize the potential for re-transmission of pathogens through clothing.

Announcing the launch of the anti-viral fabrics under INTELLIFABRIX Kulin Lalbhai, executive director, Arvind, said: “The world is facing an unprecedented crisis due to COVID-19. In this context, we are committed to keep our customers safe and that is why we have tied up with HeiQ to bring its revolutionary Viroblock technology to India. We are excited with this partnership and in a very short period of time we will introduce into the Indian market fabrics that will provide best-in-class viral protection and are fashionable at the same time.”

HeiQ Viroblock is an antiviral product created by HeiQ. HeiQ Viroblock significantly enhances the antiviral log reduction and reduces viral infectivity by 99.99 percent and claims such efficacy on SARS-CoV-2. HeiQ Viroblock has been designed to stay active on treated garments for 30 gentle domestic washes, ensuring safety for the consumer that lasts for a good part of the garment’s life, according to the company.

Talking about the partnership Carlo Centonze, CEO, HeiQ Group said: “HeiQ Viroblock is a special combination of our advanced silver and vesicle technology that has been proven effective against the human coronavirus 229E & SARS-CoV-2, causing Covid-19, with 99.99-percent reduction of virus in 30 minutes. It is a safe, hypoallergenic and patent pending technology. We are pleased to partner with Innovative Brand ‘Arvind’ in India to offer this technology across their range of products”

Posted June 10, 2020

Source: Arvind Ltd.